Pharmacokinetics and Hepatic Safety of EGCG
Diseases of the Digestive System - Liver | Women's Health
What is the purpose of this trial?
A trial to assess the pharmacokinetics and hepatic safety of EGCG in women with and without uterine fibroids.
- Ages18 years - 40 years
- GenderFemale only
- Trial withNational Institute of Child Health and Human Development (NICHD)
- Start Date07/08/2021
- End Date04/30/2021
- Last Updated11/17/2021
- Study HIC#2000028370